Real-World Evidence for Ixekizumab in the Treatment of Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis: Systematic Literature Review 2022-2023.
- DOI
- 10.1007/s12325-025-03258-9
- Published
- 2025 Sep
- Container
- Advances in therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s12325-025-03258-9,
title = {Real-World Evidence for Ixekizumab in the Treatment of Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis: Systematic Literature Review 2022-2023.},
author = {Puig L and Sewerin P and Schuster C and Ng KJ and Papadimitropoulos M and Gadagamma S and Nuñez M and Lampropoulou A},
year = {2025},
journal = {Advances in therapy},
doi = {10.1007/s12325-025-03258-9},
url = {https://doi.org/10.1007/s12325-025-03258-9}
}RIS
TY - JOUR TI - Real-World Evidence for Ixekizumab in the Treatment of Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis: Systematic Literature Review 2022-2023. AU - Puig L AU - Sewerin P AU - Schuster C AU - Ng KJ AU - Papadimitropoulos M AU - Gadagamma S AU - Nuñez M AU - Lampropoulou A PY - 2025 JO - Advances in therapy DO - 10.1007/s12325-025-03258-9 UR - https://doi.org/10.1007/s12325-025-03258-9 ER -
APA
L, P., P, S., C, S., KJ, N., M, P., S, G., M, N., & A, L. (2025). Real-World Evidence for Ixekizumab in the Treatment of Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis: Systematic Literature Review 2022-2023.. Advances in therapy. https://doi.org/10.1007/s12325-025-03258-9
Source records
- pubmed · retrieved 2026-09-25T21:39:20.111Z
- europe-pmc · retrieved 2026-09-25T21:39:20.128Z